These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 15289699

  • 1. Oral risperidone plus oral lorazepam versus standard care with intramuscular conventional neuroleptics in the initial phase of treating individuals with acute psychosis.
    Lejeune J, Larmo I, Chrzanowski W, Witte R, Karavatos A, Schreiner A, Lex A, Medori R.
    Int Clin Psychopharmacol; 2004 Sep; 19(5):259-69. PubMed ID: 15289699
    [Abstract] [Full Text] [Related]

  • 2. Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation.
    Currier GW, Simpson GM.
    J Clin Psychiatry; 2001 Mar; 62(3):153-7. PubMed ID: 11305699
    [Abstract] [Full Text] [Related]

  • 3. Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study.
    Hovens JE, Dries PJ, Melman CT, Wapenaar RJ, Loonen AJ.
    J Psychopharmacol; 2005 Jan; 19(1):51-7. PubMed ID: 15671129
    [Abstract] [Full Text] [Related]

  • 4. Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam.
    Currier GW, Chou JC, Feifel D, Bossie CA, Turkoz I, Mahmoud RA, Gharabawi GM.
    J Clin Psychiatry; 2004 Mar; 65(3):386-94. PubMed ID: 15096079
    [Abstract] [Full Text] [Related]

  • 5. Risperidone versus haloperidol, in combination with lorazepam, in the treatment of acute agitation and psychosis: a pilot, randomized, double-blind, placebo-controlled trial.
    Veser FH, Veser BD, McMullan JT, Zealberg J, Currier GW.
    J Psychiatr Pract; 2006 Mar; 12(2):103-8. PubMed ID: 16728906
    [Abstract] [Full Text] [Related]

  • 6. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [Abstract] [Full Text] [Related]

  • 7. The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapine, risperidone, and conventional antipsychotics.
    Miller CH, Mohr F, Umbricht D, Woerner M, Fleischhacker WW, Lieberman JA.
    J Clin Psychiatry; 1998 Feb; 59(2):69-75. PubMed ID: 9501888
    [Abstract] [Full Text] [Related]

  • 8. Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam for the treatment of acute schizophrenia with agitation: An open-label, randomized controlled trial.
    Huang CL, Hwang TJ, Chen YH, Huang GH, Hsieh MH, Chen HH, Hwu HG.
    J Formos Med Assoc; 2015 May; 114(5):438-45. PubMed ID: 25791540
    [Abstract] [Full Text] [Related]

  • 9. Comparison of risperidone oral solution and intramuscular haloperidol with the latter shifting to oral therapy for the treatment of acute agitation in patients with schizophrenia.
    Fang M, Chen H, Li LH, Wu R, Li Y, Liu L, Ye M, Huang J, Zhu S, Wang G, Zhang Q, Zheng H, Zhang L, Wang B, Zhou J, Zhao JP.
    Int Clin Psychopharmacol; 2012 Mar; 27(2):107-13. PubMed ID: 22233697
    [Abstract] [Full Text] [Related]

  • 10. Risperidone versus haloperidol in psychotic patients with disturbing neuroleptic-induced extrapyramidal symptoms: a double-blind, multi-center trial.
    Heck AH, Haffmans PM, de Groot IW, Hoencamp E.
    Schizophr Res; 2000 Dec 15; 46(2-3):97-105. PubMed ID: 11120421
    [Abstract] [Full Text] [Related]

  • 11. Improvements in stable patients with psychotic disorders switched from oral conventional antipsychotics therapy to long-acting risperidone.
    van Os J, Bossie CA, Lasser RA.
    Int Clin Psychopharmacol; 2004 Jul 15; 19(4):229-32. PubMed ID: 15201570
    [Abstract] [Full Text] [Related]

  • 12. Clinical improvement in 336 stable chronically psychotic patients changed from oral to long-acting risperidone: a 12-month open trial.
    Lasser RA, Bossie CA, Gharabawi GM, Baldessarini RJ.
    Int J Neuropsychopharmacol; 2005 Sep 15; 8(3):427-38. PubMed ID: 15804371
    [Abstract] [Full Text] [Related]

  • 13. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
    Tada M, Shirakawa K, Matsuoka N, Mutoh S.
    Psychopharmacology (Berl); 2004 Oct 15; 176(1):94-100. PubMed ID: 15083255
    [Abstract] [Full Text] [Related]

  • 14. Initial treatment of severe acute psychosis with fast orally disintegrating risperidone tablets.
    Normann C, Schmauss M, Bakri N, Gerwe M, Schreiner A.
    Pharmacopsychiatry; 2006 Nov 15; 39(6):209-12. PubMed ID: 17124642
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of direct transition to risperidone long-acting injectable in patients treated with various antipsychotic therapies.
    Möller HJ, Llorca PM, Sacchetti E, Martin SD, Medori R, Parellada E, StoRMi Study Group.
    Int Clin Psychopharmacol; 2005 May 15; 20(3):121-30. PubMed ID: 15812261
    [Abstract] [Full Text] [Related]

  • 16. A trial of low doses of risperidone in the treatment of patients with first-episode schizophrenia, schizophreniform disorder, or schizoaffective disorder.
    Huq ZU, RIS-GBR-32 Investigators.
    J Clin Psychopharmacol; 2004 Apr 15; 24(2):220-4. PubMed ID: 15206670
    [Abstract] [Full Text] [Related]

  • 17. Phase-IV multicentre clinical study of risperidone in the treatment of outpatients with schizophrenia. The RIS-CAN-3 Study Group.
    Chouinard G, Kopala L, Labelle A, Beauclair L, Johnson SV, Singh KI.
    Can J Psychiatry; 1998 Dec 15; 43(10):1018-25. PubMed ID: 9868567
    [Abstract] [Full Text] [Related]

  • 18. Risperidone for the treatment of behavioral and psychological symptoms of dementia.
    Tune LE.
    J Clin Psychiatry; 2001 Dec 15; 62 Suppl 21():29-32. PubMed ID: 11584986
    [Abstract] [Full Text] [Related]

  • 19. Parenteral lorazepam versus parenteral haloperidol for the control of psychotic disruptive behavior.
    Salzman C, Solomon D, Miyawaki E, Glassman R, Rood L, Flowers E, Thayer S.
    J Clin Psychiatry; 1991 Apr 15; 52(4):177-80. PubMed ID: 1673123
    [Abstract] [Full Text] [Related]

  • 20. Comparison of risperidone orodispersible tablet and intramuscular haloperidol in the treatment of acute psychotic agitation: a randomized open, prospective study.
    Lim HK, Kim JJ, Pae CU, Lee CU, Lee C, Paik IH.
    Neuropsychobiology; 2010 Apr 15; 62(2):81-6. PubMed ID: 20523078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.